About this trial
Supraventricular arrhythmias complicate more than 40% of cardiac surgeries and are associated with an increased risk of bleeding, stroke, heart failure, and death. Preventing the occurrence of these arrhythmias is a major challenge. This study aims to investigate risk factors and protective factors regarding atrial fibrillation and other iatrogenic cardiac arrhythmias after cardiac surgery, particularly innovative anesthetic strategies such as stellar ganglion blockade which have been recently implemented in our center.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
age >18
having undergone a scheduled cardiac surgery in the study center
having agreed to the reuse of their hospital care data
Disqualifiers
Atrial fibrillation at the admission in hospital.
Trial population
Patients having undergone a scheduled cardiac surgery in the study center and having agreed to the reuse of their hospital care data
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Occurrence of postoperative atrial fibrillation
monitor on cardiac ECG monitoring performed during the routine cares in cardiac ICU
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: